Model Description

Model Compartments
The mathematical model consists of five tuberculosis (TB) compartments, three of which are duplicated by drug resistance status (drug-susceptible or multidrug-resistant, MDR), yielding eight TB compartments overall. Each TB compartment is then subdivided into four HIV states (the post-IPT state into three, as IPT is not offered to people without HIV in this model), for a total of 31 total compartments. The TB compartments are: where the subscript h denotes HIV status according to the following strata:
• HIV-negative (h = 0)
• HIV-positive with CD4 + T-cell count >350 cells/mm 3 (h = 1)
• HIV-positive with CD4 + T-cell count ≤350 cells/mm 3 but not on antiretroviral therapy
[ART] (h = 2), and
• HIV-positive with CD4 + T-cell count ≤350 cells/mm 3 and on antiretroviral therapy
[ART] (h = 3).
The subscript r denotes drug resistance status as drug-susceptible (d = 0) or MDR-TB (d = 1).
We use N(t) to denote the size of the full population at time t, summing over all compartments.
Population
The model assumes an adult population (the catchment population of a given set of clinics), with no immigration or emigration. We include only individuals between the ages of 15 and 59 (to match available data in Brazil), assuming that deaths or exits (reaching one's 60 th birthday) are replaced by entries (reaching ones 15 th birthday). Entries occur primarily into the HIV uninfected, TB uninfected compartment (U 0 ), though a small number are assumed to have latent infection. The proportion entering the latently infected compartment L 0,r is estimated at baseline/equilibrium as (1 -e -15*λ ), where λ is the force of infection as below. For model simplicity (and given the relatively low force of infection), this proportion is held constant throughout the rest of the model's time horizon. Similarly, the proportion of individuals entering with latent MDR-TB infection is modeled as the relative force of infection for MDR-TB relative to drug-susceptible TB at baseline.
Description of Model Transitions: TB
Individuals exit the uninfected compartment U h at a rate that is determined by the per-person TB transmission rate, number of infectious TB cases, and the relative transmission rate σ for individuals with HIV-associated TB. A proportion of these individuals progress rapidly to active disease A h,r ; the remainder become latently infected (L h,r ), from which reactivation as well as reinfection and subsequent rapid progression to active disease (at a reduced rate) are both allowed. Individuals with latent TB infection (due to drug-susceptible TB) may also progress to the post-IPT state I h according to the "IPT initiation rate." Incomplete courses of IPT are modeled as having no effect; completed courses of IPT result in transition to the post-IPT state for the duration of the five-year analytic horizon. (As described in the main text, sensitivity analysis is performed for durations of protection as short as 6 months.) Although the duration of IPT effectiveness among HIV-infected individuals in settings of high TB transmission and/or low ART coverage is a matter of debate, we do not see any evidence of waning effectiveness in THRio trial data, and the average duration of the post-IPT state in this model (given a five-year analytic horizon with continuous deployment of IPT throughout the time period) was less than three years. Note that IPT may also be delivered to individuals without latent TB infection (e.g., false-positive tuberculin skin test), or with latent TB infection due to MDR-TB, but these individuals are assumed to receive no benefit from IPT and thus do not change their TB status.
The post-IPT state is characterized by a reduced risk of TB reactivation (assuming that one's latent TB strain is drug-susceptible), but no change in the risk of reinfection -although as described in the main text, we perform sensitivity analysis to relax this assumption as well.
After progressing to active TB, individuals can enter the recovered compartment R h,r through diagnosis and treatment or spontaneous recovery. We assume that diagnosis and treatment occur at a constant annual rate; for simplicity, we assume that individuals with MDR-TB are successfully diagnosed and treated at the same rate as those with drug-susceptible TB. Since the relative infectiousness of MDR-TB is fit to the prevalence of MDR-TB in Brazil, lowering the MDR-TB treatment rate simply results in a lower relative infectiousness of MDR-TB in this model (i.e., to maintain a constant MDR-TB prevalence at equilibrium), with little impact on model outcomes related to IPT effectiveness (data not shown). Subsequent relapse from R h,r to A h,r is allowed (encompassing both "relapse" and "reactivation" in a single parameter), as is reinfection.
Description of Model Transitions: HIV
Since the purpose of this model is to evaluate the impact of IPT on TB incidence and mortality in an HIV epidemic that is essentially at steady-state over the five-year model duration, we do not explicitly model HIV incidence as transmission events over sexual or drug-use networks.
Rather, we adopt a simplified approach that considers a constant HIV incidence rate from X 0,r to X 1,r , where X represents any of the five TB states listed above. Following HIV infection, people then progress to CD4 count ≤350 cells/mm 3 at a mean rate informed by natural history studies in the pre-ART era. Once people reach a CD4 nadir ≤350 cells/mm 3 , we assume that they are started on ART at a rate that results in population ART coverage consistent with estimates in Brazil. We also assume that people on ART discontinue or are lost to follow-up at a rate of 0.2/year; we vary this parameter widely in sensitivity analysis. The Table below Table 1 of the main text.
Model Equations
Rates of flow between compartments are governed by the system of ordinary differential equations listed in Equations 1-9. We first define the force of infection, total mortality rate, and rates of successful treatment for simplicity. 
Total mortality is the sum of baseline mortality across all compartments, plus TB-specific mortality across the compartments that correspond to active TB. Note that µ h here includes nonspecific mortality, HIV-specific mortality among those with HIV, and aging from the population at a rate of 1/(60-15) per year -i.e., the inverse of the duration of time between population entry (15 th birthday) and exit (60 th birthday).
In the following equations, equation ( 
where χ is the proportion of 15-year-olds who are latently infected, M(t) represents total mortality and aging as above, λ tot denotes the total force of infection (drug-sensitive plus MDR), µ h represents background mortality and aging, η represents HIV infection, γ represents progression of HIV disease, α in the initiation of ART, and α out the discontinuation of ART. Thus, uninfected individuals leave this compartment through infection, death, and aging; and they move through HIV strata according to HIV infection, disease progression, and ART initiation/discontinuation, with entries into U 0 (plus latent compartments below) matching exits due to mortality or aging.
Equations 2a-2d. Latently Infected Compartments (L h,r )
)
where χ is the proportion of 15-year-olds who are latently infected, M(t) represents total mortality and aging as above, λ r denotes the resistance-specific force of infection while λ tot denotes the total force of infection (drug-sensitive plus MDR), π h is the proportion of recent infections that progress rapidly to active TB, ψ 0 is the relative reduction in rapid progression after reinfection among people with latent TB and no HIV infection, ε h represents the endogenous reactivation rate, µ h represents background mortality and aging, η represents HIV infection, γ represents progression of HIV disease, α in the initiation of ART, and α out the discontinuation of ART. The term κ * (1 -φ) * r=0 is the IPT initiation rate among people with HIV and without MDR-TB, the expression r=0 equaling 1 when r = 0 and 0 when r = 1, and φ denoting the proportion of IPT treatments that result in new resistance, set pessimistically in the base case as equal to the number of recovery events from active TB that result in MDR-TB. Not shown for simplicity in the equations above is acquisition of resistance during IPT (i.e., rate of κ * φ * L h,0 from each HIV-infected compartment with r=0 into each compartment with r=1).
Thus, uninfected individuals who do not progress rapidly are modeled as developing latent infection, and latently infected individuals leave this compartment through TB reinfection (followed by rapid progression), IPT initiation, endogenous reactivation, and death. They move through HIV strata according to HIV infection, disease progression, and ART initiation/discontinuation. Note that, in this model using a 5-year time horizon, we do not explicitly model superinfection of individuals with latent TB (e.g., movement from latent/drugresistant to latent/drug-susceptible after superinfection with a susceptible strain) unless that superinfection is followed by rapid progression to active TB -as superinfection followed by progression within 5 years would, by our definition, be considered rapid progression.
Equations 3a-3c. Post-IPT Compartments (I h )
Note that IPT is only offered to those with HIV (i.e., no compartment for h=0) and is assumed to have no effect in those with MDR-TB (i.e., no compartments for r=1).
where κ is the IPT initiation rate, φ is the proportion of IPT treatments resulting in acquisition of resistance, λ tot denotes the total force of infection (drug-sensitive plus MDR), ι is the protective efficacy of IPT, π h is the proportion of recent infections that progress rapidly to active TB, ε h represents the endogenous reactivation rate, µ h represents background mortality and aging, γ represents progression of HIV disease, α in the initiation of ART, and α out the discontinuation of ART.
Thus, latently infected individuals may be placed on IPT, at which time they enter a compartment, exit from which resembles latent infection except for a degree of protection against endogenous reactivation (if the infection is drug-sensitive).
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Equations 4a-4d. Active TB Compartments (A h,r ) )
where λ r denotes the resistance-specific force of infection while λ tot denotes the total force of infection (drug-sensitive plus MDR), π h is the proportion of recent infections that progress rapidly to active TB, ψ 0 is the relative reduction in rapid progression after infection among where τ represents the combined rate of treatment and spontaneous resolution, φ is the proportion of recovery events resulting in acquisition of resistance (the indicator function r=0 implies that recoveries resulting in acquisition of resistance remain in the active compartment), λ tot denotes the total force of infection (drug-sensitive plus MDR), π h is the proportion of recent infections that progress rapidly to active TB, ρ denotes the relapse rate after successful treatment (which includes both "reactivation" and "relapse"), µ h represents background mortality and aging, η represents HIV infection, γ represents progression of HIV disease, α in the initiation of ART, and α out the discontinuation of ART.
Thus, individuals enter this compartment through successful treatment or resolution and exit through TB reinfection (followed by rapid progression), relapse, and death. They move through HIV strata according to HIV infection, disease progression, and ART initiation/discontinuation.
